Press Releases
Press Releases
More Press Releases
View Older Stories View Newer Stories-
Form 8.5 (EPT/RI) - Alliance Pharma plc
-
Fapon Biopharma Announces FDA Approval of IND for FP008, a First-in-Class Immunotherapy for Solid Tumors
-
Form 8.5 (EPT/RI) - Thruvision Group plc
-
Velcan Holdings: Share buyback program - weekly statement
-
Centenary British Heritage Brand KENT&CURWEN Returns to London Fashion Week
-
Fujitsu's Oyama plant achieves top CSR score for sustainability in global telecom audit
-
Hi-View Resources to Attend PDAC 2025
-
NUPRC Welcomes Court Ruling Upholding OML 46 Award to Halkin E&P, Reaffirming Confidence in Nigeria's Energy Sector
-
European Energy A/S: Annual report 2024
-
Ecrio Teams Up with Intel, and Canonical to Deliver AI-Powered Critical Communication Solutions
-
ION wins "Best Platform for Electronic Market Making" at Trading Tech Insight Awards Europe
-
HSBC Continental Europe: Post Stabilisation Notice
-
Municipality Finance issues EUR 25 million notes under its MTN programme
-
Huhtamaki launches recyclable single coated paper cups for yogurt and dairy
-
Municipality Finance issues EUR 20 million notes under its MTN programme
-
Lime AI Debuts at MWC 2025: A Game-Changer in Stress Management
-
ProSiebenSat.1 Extends Partnership with SES
-
Bybit Restores Assets and Confidence Through Transparent Recovery Process
-
Nxera Pharma Enters Agreement with Holling to Commercialize Daridorexant in Taiwan
-
International Paper Names New Leaders
-
Casino Group: Release of the FY 2024 presentation results
-
Casino Group: 2024 Full-Year Results
-
Oma Savings Bank Plc’s Notice of Annual General Meeting
-
Defiance Silver Provides Corporate Update
-
Unaudited financial results of VILVI Group for the 12 months of 2024
-
Pearson and AWS Announce Collaboration to Unlock AI-Powered Personalized Learning for Millions of People Globally
-
Bitget Wallet Mitigates Memecoin Volatility with Trading Rebates on BNB Chain
-
Vantage Markets Recognized as 'Most Trusted Broker' at Smart Vision Summit 2025 in Oman
-
Pearson 2024 Preliminary Results (Unaudited)
-
Mkango Resources Limited Announces Executive Compensation and Issue of Shares
-
AbbVie Receives Positive CHMP Opinion for Upadacitinib (RINVOQ®) for the Treatment of Adults with Giant Cell Arteritis
-
Olight Debuts at IWA OutdoorClassics 2025
-
AB KN Energies will hold a Webinar regarding unaudited financial results for the twelve months of 2024
-
AB KN Energies unaudited financial information for the twelve months of 2024
-
The Board of Directors of Oma Savings Bank Plc launches a new program period for the share savings plan for all personnel
-
DIGITALIST GROUP’S FINANCIAL STATEMENT RELEASE, 1 JANUARY–31 DECEMBER 2024
-
Enefit Green's unaudited financial results Q4 and 12 months of 2024
-
IDEX Biometrics ASA – Information about the first exercise period for warrants (Warrants A) issued in connection with the Private Placement and Subsequent Offering
-
NB Private Equity Partners Announces Transaction in Own Shares
-
Apranga Group interim information for 12 months of 2024
-
Innofactor Plc Financial Statements Bulletin 2024 (IFRS)
-
Texaf: COMMERCIAL SUCCESS OF THE 3 MAJOR NEW PROJECTS SUPPORTING GROWTH OF RECURRING OPERATING PROFIT (+12% in 2024)
-
Pharming Group to participate in March investor conference
-
Year end report 2024
-
Production report for January 2025
-
Tetragon Financial Group Limited January 2025 Monthly Factsheet
-
Capture Love with vivo V50: "VLOVE Portrait Gallery" Opens in Bangkok
-
Eisai Enters into License Agreement for the Development and Distribution of Fibroblast Growth Factor (FGF) Receptor Selective Tyrosine Kinase Inhibitor Tasurgratinib in Greater China Region (Mainland
-
Borregaard ASA: Shares for employees 2025
-
Paratus Reports Q4 2024 Results

